# Testosterone Effects on Pelvic Floor Muscles

> **NCT04026880** · PHASE3 · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Urinary Incontinence
- Menopause

## Interventions

- **DRUG:** Testosterone Enanthate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04026880
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funds
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026880, "Testosterone Effects on Pelvic Floor Muscles". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04026880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*